Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Virtu Financial Inc. Class A Common Stock (VIRT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Virtu Financial Inc. Class A Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.45 (market cap $4.59B), while Virtu Financial Inc. Class A Common Stock trades at $57.56 (market cap $5.10B). The key difference: Definium Therapeutics Inc. Common Shares and Virtu Financial Inc. Class A Common Stock are close in size by market cap, and Virtu Financial Inc. Class A Common Stock pays a 1.66% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Virtu Financial Inc. Class A Common Stock for 0 Days on average.
| DFTX | VIRT | |
|---|---|---|
Market Cap | $4.59B | $5.10B |
Volume | 2,103,937 | 871,626 |
Sector | Health | Financials |
52-Week High | $48.45 | $67.93 |
52-Week Low | $10.68 | $32.53 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.55B | $14.81B |
Dividend Yield | — | 1.66% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Virtu Financial Inc. Class A Common Stock
Virtu Financial provides technology-enabled market-making and execution services. Its platforms help institutional, retail, and other market participants trade across global financial markets.
Read more on VIRT →
